LOADING
Comparing Thermo Fisher Scientific (TMO) and Cisco Systems (CSCO) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | TMO | CSCO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $212.7B | $451.6B |
| P/E Ratio | 30.1 | 38.2 |
| Forward P/E | 22.4 | 24.0 |
| PEG Ratio | 1.83 | 1.58 |
| EPS | $19.14 | $3.00 |
| Revenue Growth (YoY) | 10.5% | 12.0% |
| Profit Margin | 15.0% | 19.7% |
| Return on Equity | 13.5% | 25.2% |
| Dividend Yield | 0.15% | 1.45% |
| Beta | 0.87 | 1.01 |
| 52-Week High | $642.71 | $129.88 |
| 52-Week Low | $434.83 | $64.42 |
| Volume | -- | -- |
Cisco Systems is the larger company by market capitalization. Thermo Fisher Scientific trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Cisco Systems offers a higher dividend yield for income investors. Cisco Systems has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.